Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;21(2):107-110.
doi: 10.1177/15347346221081572. Epub 2022 Feb 23.

Diabetic Foot Syndrome in the COVID-19 era: How to Move from Classical to new Approaches

Roberto Anichini  1 , Claudia Cosentino  1 , Nikolaos Papanas  2
Affiliations

Diabetic Foot Syndrome in the COVID-19 era: How to Move from Classical to new Approaches

Roberto Anichini et al. Int J Low Extrem Wounds. 2022 Jun.

Abstract

Diabetic foot syndrome (DFS) is a major complication of diabetes mellitus. Coronavirus infectious disease 2019 (COVID-19) has created new necessities and priorities in DFS management. These include telemedicine and patient triage to minimise hospitalisation and visits to the clinic. Moreover, new studies will be needed to evaluate whether the lockdown in patients with DFS or in those with high risk of DFS have increased the risk of deteriorating outcomes, including limb loss. Our future challenge will lie in re-organising our world during the pandemic and after its resolution. We need more awareness of the widespread ways of the changes in taking care of patients and to improve education, skills, and behaviour of high-risk patients.

Keywords: COVID-19; diabetic foot; diabetic foot ulcers; management; telemedicine.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: C. Cosentino personal fees by Lilly. R. Anichini, no conflict of interest for this paper and has been an advisory board member or speaker for Angelini, Molteni, Eli Lilly, Astra Zeneca; Takeda, Boeringher Ingelheim, Sanofi, Merck. N. Papanas has been an advisory board member of Astra-Zeneca, Boehringer Ingelheim, MSD, Novo Nordisk, Pfizer, Takeda and TrigoCare International; has participated in sponsored studies by Astra-Zeneca, Eli-Lilly, GSK, MSD, Novo Nordisk, Novartis and Sanofi-Aventis; has received honoraria as a speaker for Astra-Zeneca, Boehringer Ingelheim, Eli-Lilly, ELPEN, Galenica, MSD, Mylan, Novo Nordisk, Pfizer, Sanofi-Aventis, Takeda and Vianex; and attended conferences sponsored by TrigoCare International, Eli-Lilly, Galenica, Novo Nordisk, Pfizer and Sanofi-Aventis.

Comment in

  • Sweet Sunshine of Science.
    Papanas N, Papi M, Rerkasem K. Papanas N, et al. Int J Low Extrem Wounds. 2022 Jun;21(2):105-106. doi: 10.1177/15347346221096031. Int J Low Extrem Wounds. 2022. PMID: 35469456 No abstract available.

References

    1. Holman N, Knighton P, Kar P, et al.Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8(10):823-833. - PMC - PubMed
    1. Barron E, Bakhai C, Kar P, et al.Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020;8(10):813-822. - PMC - PubMed
    1. Papanas N, Papachristou S. COVID-19 and diabetic foot: will the lamp burn bright? Int J Low Extrem Wounds. 2020;19(2):111. - PubMed
    1. Volmer-Thole M, Lobmann R. Neuropathy and diabetic foot syndrome. Int J Mol Sci. 2016;17(6):917. - PMC - PubMed
    1. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49(2):106-116. - PubMed